Engineered immune cells as highly sensitive cancer diagnostics

Endogenous biomarkers remain at the forefront of early disease detection efforts, but many lack the sensitivities and specificities necessary to influence disease management. Inspired by emerging adoptive cell transfer immunotherapies and the natural migration of immune cells to pathology, here we d...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Nat Biotechnol
Auteurs principaux: Aalipour, Amin, Chuang, Hui-Yen, Murty, Surya, D’Souza, Aloma L., Park, Seung-min, Gulati, Gunsagar S., Patel, Chirag B., Beinat, Corinne, Simonetta, Federico, Martinić, Ivana, Gowrishankar, Gayatri, Robinson, Elise R., Aalipour, Eamon, Zhian, Zahra, Gambhir, Sanjiv S.
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7295609/
https://ncbi.nlm.nih.gov/pubmed/30886438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41587-019-0064-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires